The physiology and clinical management of glucose metabolism in the newborn

Endocrine Development

Volumn 12, Issue , 2007, Pages 124-137

  Beardsall, K ^a   Dunger, D ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE;

ARTICLE; DELIVERY; FEMALE; FETUS; HUMAN; HYPERGLYCEMIA; METABOLISM; NEWBORN; PHYSIOLOGY; PREGNANCY; VERY LOW BIRTH WEIGHT;

DELIVERY, OBSTETRIC; FEMALE; FETUS; GLUCOSE; HUMANS; HYPERGLYCEMIA; INFANT, NEWBORN; INFANT, VERY LOW BIRTH WEIGHT; PREGNANCY;

EID: 38449118141     PISSN: 14217082     EISSN: 16622979     Source Type: Book Series    
DOI: 10.1159/000109639     Document Type: Conference Paper

References (69)

1. Illsley NP: Glucose transporters in the human placenta. Placenta 2000;21:14-22.
2. Boden G: Fuel metabolism in pregnancy and in gestational diabetes mellitus. Obstet Gynecol Clin North Am 1996;23:1-10.
3. Gaither K, Quraishi AN, Illsley NP: Diabetes alters the expression and activity of the human placental GLUT1 glucose transporter. J Clin Endocrinol Metab 1999;84:695-701.
4. Baumann MU, Deborde S, Illsley NP: Placental glucose transfer and fetal growth. Endocrine 2002;19:13-22.
5. Hay WW Jr, Sparks JW: Placental, fetal, and neonatal carbohydrate metabolism. Clin Obstet Gynecol 1985;28:473-485.
6. Jansson T, Ylven K, Wennergren M, Powell TL: Glucose transport and system A activity in syncytiotrophoblast microvillous and basal plasma membranes in intrauterine growth restriction. Placenta 2002;23:392-399.
7. Herrera E, Amusquivar E: Lipid metabolism in the fetus and the newborn. Diabetes Metab Res Rev 2000;16:202-210.
8. van Aerde JE, Wilke MS, Feldman M, Clandinin MT: Accretion of lipid in the fetus and newborn; in Polin RA, Fox WW, Abman SH (eds): Fetal and Neonatal Physiology, ed 3. Philadelphia, Saunders, 2003, vol 1, 3, pp 388-404.
9. Bernstein I: Fetal body composition. Curr Opin Clin Nutr Metab Care 2005;8:613-617.
10. Fowden AL: The role of insulin in prenatal growth. J Dev Physiol 1989;12:173-182.
11. Fowden AL, Hughes P, Comline RS: The effects of insulin on the growth rate of the sheep fetus during late gestation. Q J Exp Physiol 1989;74:703-714.
12. Hill DJ, Petrik J, Arany E: Growth factors and the regulation of fetal growth. Diabetes Care 1998;21(suppl 2):B60-B69.
13. Hill DJ, Duvillie B: Pancreatic development and adult diabetes. Pediatr Res 2000;48:269-274.
14. Susa JB, Schwartz R: Effects of hyperinsulinemia in the primate fetus. Diabetes 1985;34(suppl 2):36-41.
15. Ostlund I, Hanson U, Bjorklund A, Hjertberg R, Eva N, Nordlander E, Swahn ML, Wager J: Maternal and fetal outcomes if gestational impaired glucose tolerance is not treated. Diabetes Care 2003;26:2107-2111.
16. Oliver MH, Harding JE, Breier BH, Gluckman PD: Fetal insulin-like growth factor (IGF)-I and IGF-II are regulated differently by glucose or insulin in the sheep fetus. Reprod Fertil Dev 1996;8:167-172.
17. Gluckman PD, Butler JH, Comline R, Fowden A: The effects of pancreatectomy on the plasma concentrations of insulin-like growth factors 1 and 2 in the sheep fetus. J Dev Physiol 1987;9:79-88.
18. Ong K, Kratzsch J, Kiess W, Costello M, Scott C, Dunger D: Size at birth and cord blood levels of insulin, insulin-like growth factor I (IGF-I), IGF-II, IGF-binding protein-1 (IGFBP-1), IGFBP-3, and the soluble IGF-II/mannose-6- phosphate receptor in term human infants. The ALSPAC Study Team. Avon Longitudinal Study of Pregnancy and Childhood. J Clin Endocrinol Metab 2000;85:4266-4269.
19. Economides DL, Proudler A, Nicolaides KH: Plasma insulin in appropriate and small for gestational age fetuses. Am J Obstet Gynecol 1989;160:1091-1094.
20. Economides DL, Nicolaides KH, Campbell S: Metabolic and endocrine findings in appropriate and small for gestational age fetuses. J Perinat Med 1991;19:97-105.
21. Sperling MA, Ganguli S, Leslie N, Landt K: Fetal-perinatal catecholamine secretion: role in perinatal glucose homeostasis. Am J Physiol 1984;247:E69-E74.
22. Fowden AL: Effects of adrenaline and amino acids on the release of insulin in the sheep fetus. J Endocrinol 1980;87:113-121.
23. Burchell A, Gibb L, Waddell ID, Giles M, Hume R: The ontogeny of human hepatic microsomal glucose-6-phosphatase proteins. Clin Chem 1990;36:1633-1637.
24. Hume R, Burchell A: Abnormal expression of glucose-6-phosphatase in preterm infants. Arch Dis Child 1993;68:202-204.
25. Scaglia L, Cahill CJ, Finegood DT, Bonner-Weir S: Apoptosis participates in the remodeling of the endocrine pancreas in the neonatal rat. Endocrinology 1997;138:1736-1741.
26. Kassem SA, Ariel I, Thornton PS, Scheimberg I, Glaser B: Beta-cell proliferation and apoptosis in the developing normal human pancreas and in hyperinsulinism of infancy. Diabetes 2000;49:1325-1333.
27. Petrik J, Arany E, McDonald TJ, Hill DJ: Apoptosis in the pancreatic islet cells of the neonatal rat is associated with a reduced expression of insulin-like growth factor II that may act as a survival factor. Endocrinology 1998;139:2994-3004.
28. Petrik J, Pell JM, Arany E, McDonald TJ, Dean WL, Reik W, Hill DJ: Overexpression of insulin-like growth factor-II in transgenic mice is associated with pancreatic islet cell hyperplasia. Endocrinology 1999;140:2353-2363.
29. Bougneres PF: Stable isotope tracers and the determination of fuel fluxes in newborn infants. Biol Neonate 1987;52(suppl 1):87-96.
30. Philipps AF, Dubin JW, Raye JR: Maturation of early-phase insulin release in the neonatal lamb. Biol Neonate 1981;39:225-231.
31. Mitanchez-Mokhtari D, Lahlou N, Kieffer F, Magny JF, Roger M, Voyer M: Both relative insulin resistance and defective islet beta-cell processing of proinsulin are responsible for transient hyperglycemia in extremely preterm infants. Pediatrics 2004;113:537-541.
32. Iniguez G, Ong K, Bazaes R, Avila A, Salazar T, Dunger D, Mericq V: Longitudinal changes in insulin-like growth factor-I, insulin sensitivity, and secretion from birth to age three years in small-for-gestational-age children. J Clin Endocrinol Metab 2006;91:4645-4649.
33. Srinivasan G, Pildes RS, Cattamanchi G, Voora S, Lilien LD: Plasma glucose values in normal neonates: a new look. J Pediatr 1986;109:114-117.
34. Koh TH, Aynsley-Green A, Tarbit M, Eyre JA: Neural dysfunction during hypoglycaemia. Arch Dis Child 1988;63:1353-1358.
35. Lucas A, Morley R, Cole TJ: Adverse neurodevelopmental outcome of moderate neonatal hypoglycaemia. BMJ 1988;297:1304-1308.
36. Hawdon JM, Ward Platt MP, Aynsley-Green A: Patterns of metabolic adaptation for preterm and term infants in the first neonatal week. Arch Dis Child 1992;67:357-365.
37. Van den Berghe G, Wouters P, Weekers F, Verwaest C, Brunyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R: Intensive insulin therapy in critically ill patients. N Engl J Med 2001;345:1359-1367.
38. Watterberg KL: Adrenocortical function and dysfunction in the fetus and neonate. Semin Neonatol 2004;9:13-21.
39. Haymond MW, Karl IE, Pagliara AS: Increased gluconeogenic substrates in the small-for-gestational-age infant. N Engl J Med 1974;291:322-328.
40. Hawdon JM, Ward Platt MP: Metabolic adaptation in small for gestational age infants. Arch Dis Child 1993;68:262-268.
41. Sunehag A, Ewald U, Gustafsson J: Extremely preterm infants (<28 weeks) are capable of gluconeogenesis from glycerol on their first day of life. Pediatr Res 1996;40:553-557.
42. Diderholm B, Ewald U, Ahlsson F, Gustafsson J: Energy substrate production in infants born small for gestational age. Acta Paediatr 2007;96:29-34.
43. Keshen T, Miller R, Jahoor F, Jaksic T, Reeds PJ: Glucose production and gluconeogenesis are negatively related to body weight in mechanically ventilated, very low birth weight neonates. Pediatr Res 1997;41:132-138.
44. Ng SM, May JE, Emmerson AJ: Continuous insulin infusion in hyperglycaemic extremely-low-birthweight neonates. Biol Neonate 2005;87:269-272.
45. Finberg L: Dangers to infants caused by changes in osmolal concentration. Pediatrics 1967;40:1031-1034.
46. Hawdon JM, Aynsley-Green A, Alberti KG, Ward Platt MP: The role of pancreatic insulin secretion in neonatal glucoregulation. 1. Healthy term and preterm infants. Arch Dis Child 1993;68:274-279.
47. Garofano A, Czernichow P, Breant B: In utero undernutrition impairs rat beta-cell development. Diabetologia 1997;40:1231-1234.
48. Alvarez C, Martin MA, Goya L, Bertin E, Portha B, Pascual-Leone AM: Contrasted impact of maternal rat food restriction on the fetal endocrine pancreas. Endocrinology 1997;138:2267-2273.
49. Farrag HM, Nawrath LM, Healey JE, Dorcus EJ, Rapoza RE, Oh W, Cowett RM: Persistent glucose production and greater peripheral sensitivity to insulin in the neonate vs the adult. Am J Physiol 1997;272:E86-E93.
50. Ogata ES: Carbohydrate homeostasis; in Avery GB, Fletcher MA, MacDonald MG (eds): Neonatology: Pathophysiology and Management of the Newborn, ed 5. Philadelphia, Lippincott Williams & Wilkins, 1999, pp 699-714.
51. Baggio LL, Drucker DJ: Biology of incretins: GLP-1 and GIP. Gastroenterology 2007;132:2131-2157.
52. Ogilvy-Stuart AL, Hands SJ, Adcock CJ, Holly JM, Matthews DR, Mohamed-Ali V, Yudkin JS, Wilkinson AR, Dunger DB: Insulin, insulin-like growth factor I (IGF-I), IGF-binding protein-1, growth hormone, and feeding in the newborn. J Clin Endocrinol Metab 1998;83:3550-3557.
53. Amin R, Ross K, Acerini CL, Edge JA, Warner J, Dunger DB: Hypoglycemia prevalence in prepubertal children with type 1 diabetes on standard insulin regimen: use of continuous glucose monitoring system. Diabetes Care 2003;26:662-667.
54. Beardsall K, Ogilvy-Stuart AL, Ahluwalia J, Thompson M, Dunger DB: The continuous glucose monitoring sensor in neonatal intensive care. Arch Dis Child Fetal Neonatal Ed 2005;90:F307-F310.
55. Hall NJ, Peters M, Eaton S, Pierro A: Hyperglycemia is associated with increased morbidity and mortality rates in neonates with necrotizing enterocolitis. J Pediatr Surg 2004;39:898-901.
56. Hays SP, Smith EO, Sunehag AL: Hyperglycemia is a risk factor for early death and morbidity in extremely low birth-weight infants. Pediatrics 2006;118:1811-1818.
57. Kao LS, Morris BH, Lally KP, Stewart CD, Huseby V, Kennedy KA: Hyperglycemia and morbidity and mortality in extremely low birth weight infants. J Perinatol 2006;26:730-736.
58. Ertl T, Gyarmati J, Gaal V, Szabo I: Relationship between hyperglycemia and retinopathy of prematurity in very low birth weight infants. Biol Neonate 2006;89:56-59.
59. Blanco CL, Baillargeon JG, Morrison RL, Gong AK: Hyperglycemia in extremely low birth weight infants in a predominantly Hispanic population and related morbidities. J Perinatol 2006;26:737-741.
60. Hikino S, Ihara K, Yamamoto J, Takahata Y, Nakayama H, Kinukawa N, Narazaki Y, Hara T: Physical growth and retinopathy in preterm infants: involvement of IGF-I and GH. Pediatr Res 2001;50:732-736.
61. Hellstrom A, Engstrom E, Hard AL, Albertsson-Wikland K, Carlsson B, Niklasson A, Lofqvist C, Svensson E, Holm S, Ewald U, et al: Postnatal serum insulin-like growth factor I deficiency is associated with retinopathy of prematurity and other complications of premature birth. Pediatrics 2003;112:1016-1020.
62. Van den Berghe G, Wouters PJ, Bouillon R, Weekers F, Verwaest C, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P: Outcome benefit of intensive insulin therapy in the critically ill: insulin dose versus glycemic control. Crit Care Med 2003;31:359-366.
63. Hey E: Hyperglycaemia and the very preterm baby. Semin Fetal Neonatal Med 2005;10:377-387.
64. Collins JW, Hoppe M, Brown K, Edidin D, Padbury J, Ogata E: A controlled trial of insulin infusion and parentral nutrition in extremely low birth weight infants with glucose intolerance. J Pediatr 1991;118:921-927.
65. Binder N, Raschko P, Benda G, Reynolds J: Insulin infusion with parenteral nutrition in extremely low birth weight infants with hyperglycaemia. J Pediatr 1989;114:273-280.
66. Ostertag S, Jovanovic L, Lewis B, Auld P: Insulin pump therapy in the very low birth weight infant. Pediatrics 1986;78:625-630.
67. Poindexter BB, Karn CA, Denne SC: Exogenous insulin reduces proteolysis and protein synthesis in extremely low birth weight infants. J Pediatr 1998;132:948-953.
68. Keller A, Keller E, Hermanussen M, Vogtmann C: Short-term growth of premature infants treated with dexamethasone assessed by mini-knemometry. Ann Hum Biol 2004;31:389-397.
69. Beardsall K, Ogilvy-Stuart AL, Frystyk J, Chen JW, Thompson M, Ahluwalia J, Ong KK, Dunger DB: Early elective insulin therapy can reduce hyperglycemia and increase insulin-like growth factor-1 levels in very low birth weight infants. J Pediatrics DOI:10.1016/j.jpeds.2007.04.068.